Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients.

Riordan HD, Casciari JJ, González MJ, Riordan NH, Miranda-Massari JR, Taylor P, Jackson JA.

P R Health Sci J. 2005 Dec;24(4):269-76.

PMID:
16570523
3.

Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.

Moen MD, Lyseng-Williamson KA, Scott LJ.

Drugs. 2009;69(3):361-92. doi: 10.2165/00003495-200969030-00010. Review.

PMID:
19275278
5.

Safety and tolerability of donepezil at doses up to 20 mg/day: results from a pilot study in patients with Alzheimer's disease.

Doody RS, Corey-Bloom J, Zhang R, Li H, Ieni J, Schindler R.

Drugs Aging. 2008;25(2):163-74.

PMID:
18257603
6.

Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbate.

Duconge J, Miranda-Massari JR, Gonzalez MJ, Jackson JA, Warnock W, Riordan NH.

P R Health Sci J. 2008 Mar;27(1):7-19. Review.

PMID:
18450228
7.

Protocol for the use of vitamin C in the treatment of cancer.

Cameron E.

Med Hypotheses. 1991 Nov;36(3):190-4.

PMID:
1787808
8.

Long-term (120-Week) antiviral efficacy and tolerability of fosamprenavir/ritonavir once daily in therapy-naive patients with HIV-1 infection: an uncontrolled, open-label, single-arm follow-on study.

Gathe JC Jr, Wood R, Sanne I, DeJesus E, Schürmann D, Gladysz A, Garris C, Givens N, Elston R, Yeo J.

Clin Ther. 2006 May;28(5):745-54.

PMID:
16861096
9.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
10.

A phase I clinical trial of the histone deacetylase inhibitor belinostat in patients with advanced hematological neoplasia.

Gimsing P, Hansen M, Knudsen LM, Knoblauch P, Christensen IJ, Ooi CE, Buhl-Jensen P.

Eur J Haematol. 2008 Sep;81(3):170-6. doi: 10.1111/j.1600-0609.2008.01102.x. Epub 2008 May 27.

PMID:
18510700
11.

Augmentation of respiratory tract lining fluid ascorbate concentrations through supplementation with vitamin C.

Behndig AF, Blomberg A, Helleday R, Kelly FJ, Mudway IS.

Inhal Toxicol. 2009 Feb;21(3):250-8. doi: 10.1080/08958370802474736 .

PMID:
19009458
12.

High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer.

Ohno S, Ohno Y, Suzuki N, Soma G, Inoue M.

Anticancer Res. 2009 Mar;29(3):809-15. Review.

14.
15.

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.

Bokemeyer C, Aapro MS, Courdi A, Foubert J, Link H, Osterborg A, Repetto L, Soubeyran P; European Organisation for Research and Treatment of Cancer (EORTC) Taskforce for the Elderly.

Eur J Cancer. 2007 Jan;43(2):258-70. Epub 2006 Dec 19. Review.

PMID:
17182241
18.

Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.

Wohlreich MM, Mallinckrodt CH, Prakash A, Watkin JG, Carter WP.

Depress Anxiety. 2007;24(1):41-52.

PMID:
16845641
19.

Intravenous vitamin C as a chemotherapy agent: a report on clinical cases.

Riordan HD, Riordan NH, Jackson JA, Casciari JJ, Hunninghake R, González MJ, Mora EM, Miranda-Massari JR, Rosario N, Rivera A.

P R Health Sci J. 2004 Jun;23(2):115-8.

PMID:
15377059
20.

Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent.

Riordan NH, Riordan HD, Meng X, Li Y, Jackson JA.

Med Hypotheses. 1995 Mar;44(3):207-13.

PMID:
7609676

Supplemental Content

Support Center